Prostatic Neoplasm Clinical Trials in Boston, Massachusetts
5 recruitingBoston, Massachusetts
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Prostate CancerProstatic Neoplasms
Merck Sharp & Dohme LLC1,440 enrolled281 locationsNCT06925737
Recruiting
Prostate Active Surveillance Study
Prostatic Neoplasms
University of Washington3,000 enrolled11 locationsNCT00756665
Recruiting
Phase 2
RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
Prostate CancerProstatic Neoplasms
Dana-Farber Cancer Institute110 enrolled3 locationsNCT05765500
Recruiting
Phase 1Phase 2
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Endometrial CancerAdvanced Solid TumorDiffuse Large B Cell Lymphoma+5 more
Novartis Pharmaceuticals275 enrolled60 locationsNCT04104776
Recruiting
Prostate Cancer Genetic Risk Evaluation and Screening Study
Prostate CancerBRCA1 MutationBRCA2 Mutation+5 more
Massachusetts General Hospital400 enrolled1 locationNCT05129605